tiprankstipranks
Advertisement
Advertisement

SNYNF Stock Latest News

Sanofi Shuts Down Early Cancer Drug Trial, Trimming One Piece of Its Oncology Pipeline
Company AnnouncementsSanofi Shuts Down Early Cancer Drug Trial, Trimming One Piece of Its Oncology Pipeline
8d ago
SNYNF
Sanofi Updates Share Capital and Voting Rights as of July 31, 2026
PremiumCompany Announcements
Sanofi Updates Share Capital and Voting Rights as of July 31, 2026
9d ago
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
PremiumThe Fly
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
11d ago
SNY
Midday Fly By: Intel announces $15B offering, Meta unveils Muse Glimmer
PremiumThe Fly
Midday Fly By: Intel announces $15B offering, Meta unveils Muse Glimmer
12d ago
BA
ACH
Sanofi facing shortages of two drugs for Pompe disease, STAT reports
PremiumThe Fly
Sanofi facing shortages of two drugs for Pompe disease, STAT reports
12d ago
SNY
Sanofi Wins EU Nod to Use MenQuadfi in Infants From Six Weeks
PremiumCompany AnnouncementsSanofi Wins EU Nod to Use MenQuadfi in Infants From Six Weeks
18d ago
Regeneron price target raised to $737 from $696 at RBC Capital
Premium
The Fly
Regeneron price target raised to $737 from $696 at RBC Capital
22d ago
SNY
REGN
Sanofi Publishes 2026 Half-Year Financial Report for Investors
Premium
Company Announcements
Sanofi Publishes 2026 Half-Year Financial Report for Investors
23d ago
Morning Movers: Baxter surges following beat and raise report
PremiumThe Fly
Morning Movers: Baxter surges following beat and raise report
23d ago
MO
BAX
Sanofi expects FY26 sales to grow by around 10% at CER
PremiumThe Fly
Sanofi expects FY26 sales to grow by around 10% at CER
23d ago
SNY
Sanofi reports Q2 business EPS EUR 2.09, up 31.4% reported
PremiumThe Fly
Sanofi reports Q2 business EPS EUR 2.09, up 31.4% reported
23d ago
SNY
Sanofi boosts 2026 outlook after strong Q2 driven by Dupixent and new launches
PremiumCompany Announcements
Sanofi boosts 2026 outlook after strong Q2 driven by Dupixent and new launches
23d ago
Sanofi’s Sarclisa Real‑World Data: What the Latest Multiple Myeloma Update Means for Investors
PremiumCompany AnnouncementsSanofi’s Sarclisa Real‑World Data: What the Latest Multiple Myeloma Update Means for Investors
24d ago
SNYNF
Sanofi ends amLitelimab program in atopic dermatitis amid portfolio review
Premium
Company Announcements
Sanofi ends amLitelimab program in atopic dermatitis amid portfolio review
29d ago
Sanofi’s Amlitelimab Trial Completion Sets Up a Key Atopic Dermatitis Catalyst
Premium
Company Announcements
Sanofi’s Amlitelimab Trial Completion Sets Up a Key Atopic Dermatitis Catalyst
1M ago
SNYNF
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
PremiumThe Fly
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
1M ago
XE
AAL
Sanofi Streamlines Executive Committee Ahead of Next Strategic Chapter
PremiumCompany Announcements
Sanofi Streamlines Executive Committee Ahead of Next Strategic Chapter
1M ago
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
PremiumThe Fly
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
1M ago
AZN
BMY
Sanofi announces Executive Committee to support next strategic chapter
PremiumThe Fly
Sanofi announces Executive Committee to support next strategic chapter
1M ago
SNY
Real-World Asthma Data on Dupixent: What Regeneron and Sanofi Investors Should Know
PremiumCompany AnnouncementsReal-World Asthma Data on Dupixent: What Regeneron and Sanofi Investors Should Know
1M ago
REGN
Ligand price target raised to $345 from $330 at Craig-Hallum
Premium
The Fly
Ligand price target raised to $345 from $330 at Craig-Hallum
1M ago
SNY
LGND
Sanofi’s iGlarLixi Diabetes Trial Nears Readout: What Investors Should Watch
Premium
Company Announcements
Sanofi’s iGlarLixi Diabetes Trial Nears Readout: What Investors Should Watch
1M ago
SNYNF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >